Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

被引:0
|
作者
Robert S. Ames
Henry M. Sarau
Johathan K. Chambers
Robert N. Willette
Nambi V. Aiyar
Anne M. Romanic
Calvert S. Louden
James J. Foley
Charles F. Sauermelch
Robert W. Coatney
Zhaohui Ao
Jyoti Disa
Stephen D. Holmes
Jeffrey M. Stadel
John D. Martin
Wu-Schyong Liu
George I. Glover
Shelagh Wilson
Dean E. McNulty
Catherine E. Ellis
Nabil A. Elshourbagy
Usman Shabon
John J. Trill
Douglas W. P. Hay
Eliot H. Ohlstein
Derk J. Bergsma
Stephen A. Douglas
机构
[1] Departments of Molecular Biology,
[2] Departments of Pulmonary and Cardiovascular Pharmacology,undefined
[3] ,undefined
[4] Departments of Functional Gene Analysis,undefined
[5] Departments of Pathology,undefined
[6] Laboratory Animal Sciences,undefined
[7] Departments of Immunology,undefined
[8] Protein Biochemistry and ,undefined
[9] Gene Expression Sciences,undefined
[10] Smith Kline Beecham Pharmaceuticals,undefined
来源
Nature | 1999年 / 401卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Urotensin-II (U-II) is a vasoactive ‘somatostatin-like’ cyclic peptide which was originally isolated from fish spinal cords1,2, and which has recently been cloned from man3. Here we describe the identification of an orphan human G-protein-coupled receptor homologous to rat GPR14 (refs 4, 5) and expressed predominantly in cardiovascular tissue, which functions as a U-II receptor. Goby and human U-II bind to recombinant human GPR14 with high affinity, and the binding is functionally coupled to calcium mobilization. Human U-II is found within both vascular and cardiac tissue (including coronary atheroma) and effectively constricts isolated arteries from non-human primates. The potency of vasoconstriction of U-II is an order of magnitude greater than that of endothelin-1, making human U-II the most potent mammalian vasoconstrictor identified so far. In vivo, human U-II markedly increases total peripheral resistance in anaesthetized non-human primates, a response associated with profound cardiac contractile dysfunction. Furthermore, as U-II immunoreactivity is also found within central nervous system and endocrine tissues, it may have additional activities.
引用
收藏
页码:282 / 286
页数:4
相关论文
共 50 条
  • [1] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    NATURE, 1999, 401 (6750) : 282 - 286
  • [2] Erratum: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Robert S. Ames
    Henry M. Sarau
    Johathan K. Chambers
    Robert N. Willette
    Nambi V. Aiyar
    Anne M. Romanic
    Calvert S. Louden
    James J. Foley
    Charles F. Sauermelch
    Robert W. Coatney
    Zhaohui Ao
    Jyoti Disa
    Stephen D. Holmes
    Jeffrey M. Stadel
    John D. Martin
    Wu-Schyong Liu
    George I. Glover
    Shelagh Wilson
    Dean E. McNulty
    Catherine E. Ellis
    Nabil A. Elshourbagy
    Usman Shabon
    John J. Trill
    Douglas W. P. Hay
    Eliot H. Ohlstein
    Derk J. Bergsma
    Stephen A. Douglas
    Nature, 1999, 402 : 898 - 898
  • [3] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999)
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    NATURE, 1999, 402 (6764) : 898 - 898
  • [4] Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14)
    Mori, M
    Sugo, T
    Abe, M
    Shimomura, Y
    Kurihara, M
    Kitada, C
    Kikuchi, K
    Shintani, Y
    Kurokawa, T
    Onda, H
    Nishimura, O
    Fujino, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) : 123 - 129
  • [5] Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14
    Liu, QY
    Pong, SS
    Zeng, ZZ
    Zhang, Q
    Howard, AD
    Williams, DL
    Davidoff, M
    Wang, RP
    Austin, CP
    McDonald, TP
    Bai, C
    George, SR
    Evans, JF
    Caskey, CT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (01) : 174 - 178
  • [6] Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain
    Gartlon, JE
    Ashmeade, T
    Duxon, M
    Hagan, JJ
    Jones, DNC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 493 (1-3) : 95 - 98
  • [7] Urotensin-II, the neuropeptide ligand for GPR14, induces C-fos in the rat brain
    Gartlon, J
    Ashmeade, T
    Duxon, M
    Hagan, JJ
    Jones, DNC
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136
  • [8] Two isoforms of the novel urotensin-II receptor, GPR14, differ in their capacity to mediate intracellular inositol phosphate accumulation
    Herold, CL
    Douglas, SA
    CIRCULATION, 2001, 104 (17) : 62 - 62
  • [9] Increased expression of urotensin 2 and urotensin receptor GPR14 in human diabetic nephropathy.
    Langham, RG
    Gow, RM
    Thomson, NM
    Dowling, JK
    Gilbert, RE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 600A - 600A
  • [10] Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta
    Bousette, N
    Patel, L
    Douglas, SA
    Ohlstein, EH
    Giaid, A
    ATHEROSCLEROSIS, 2004, 176 (01) : 117 - 123